SCHEMBL28909751

SCHEMBL28909751

Cc1ccc(NC(=O)c2ccc(CNC(=O)O)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.69
RAB9A P51151 5/20 0.69
NAMPT P43490 4/20 0.67
SMN1; SMN2 Q16637 4/20 0.63
MAPT P10636 2/20 0.63
TP53 P04637 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
HPGD P15428 1/20 0.59
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 1/20 0.56
HTT P42858 1/20 0.56
MAPK14 Q16539 1/20 0.56
POLB P06746 1/20 0.54
LMNA P02545 1/20 0.53
CCR5 P51681 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15651774 0.88 POLB (0.69) NPC1RAB9ANAMPTSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10693788 0.84 NAMPT (0.60) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL1439066 0.83 NAMPT (0.67) NAMPTSMN1; SMN2KMT2AKDM4EHTT
SCHEMBL12310125 0.83 RAB9A (1.00) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL3662909 0.83 SMN1; SMN2 (0.71) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL822378 0.83 RAB9A (1.00) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL27181403 0.83 RAB9A (1.00) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL15214321 0.83 RAB9A (1.00) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL14580374 0.83 RAB9A (1.00) NPC1RAB9ANAMPTSMN1; SMN2MAPT
SCHEMBL10685426 0.83 NR1H4 (0.73) NPC1RAB9ASMN1; SMN2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112472699-A Combination methods for improving the therapeutic benefit of bisantrene and derivatives 种族肿瘤学公司 2021-03-12 CN disclosed